Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvy Gabel

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 15, 2018
In vivo coupling of tau pathology and cortical thinning in Alzheimer's diseaseElijah Mak, Richard A I Bethlehem, Rafael Romero-Garcia, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 15, 2018
In vivo coupling of tau pathology and cortical thinning in Alzheimer's diseaseElijah Mak, Richard A I Bethlehem, Rafael Romero-Garcia, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Pageof 3